Resolutions at Getinge’s Annual General Meeting
At the Annual General Meeting of Getinge AB held on 25 March 2015, the following was resolved.
Election of Board of Directors
Carl Bennet (Chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Malin Persson, Johan Stern and Maths Wahlström were re-elected as members of the Board. Alex Myers was elected new member of the Board
Fees to the Board of Directors
It was resolved that remuneration to the Board of Directors shall, unchanged, amount to a total of SEK 4,400,000 excluding remuneration for Committee work, of which SEK 1,100,000 to the Chairman and SEK 550,000 to each of the other Board members elected by the Meeting who are not employees of Getinge Group. In addition hereto, the Meeting resolved that work in the Audit Committee shall, unchanged, be compensated with SEK 240,000 to the Chairman and SEK 120,000 to each of the other members, while work in the Remuneration Committee work shall be, unchanged, compensated with SEK 125,000 to the Chairman and SEK 92,000 to each of the other members.
In accordance with the proposal of the Board of Directors and the CEO, the Annual General Meeting resolved to declare a dividend of SEK 2.80 per share. Tuesday 27 March 2015 was determined as record date for dividend.
Guidelines for Remuneration to Senior Executives
The Annual General Meeting approved the proposal of the Board regarding guidelines for remuneration to senior executives, which principally involve the following. Remuneration and other terms and conditions of employment for senior executives shall be based on market conditions and be competitive in all markets where Getinge operates, to ensure that competent and skilful employees can be attracted, motivated and retained. The total remuneration to senior executives shall comprise basic salary, variable remuneration, pensions and other benefits. The variable remuneration shall be limited and connected to predetermined and measurable criteria elaborated with the purpose to promote the long-term added value of the company. The Board shall retain the right to deviate from the guidelines if motivated by particular reasons on an individual basis.
For further information, please contact:
Alex Myers Ulf Grunander
CEO, Getinge Group CFO, Getinge Group
Tel: +46 10 335 00 00 Tel: +46 10 335 55 80
E-mail: email@example.com E-mail: firstname.lastname@example.org
About Getinge Group
The Getinge Group is a global leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. The Group is divided into three business areas: Extended Care, Infection Control and Medical Systems, and operates under the brands ArjoHuntleigh, Getinge and Maquet.
Getinge AB discloses the information herein in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 25 March 2015 at 18.00 CET.